Pictet Asset Management’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.6M Sell
110,665
-45,903
-29% -$12.2M 0.03% 425
2025
Q4
$38.6M Sell
156,568
-40,336
-20% -$8.49M 0.04% 377
2025
Q3
$34.8M Buy
196,904
+66,367
+51% +$9.93M 0.03% 396
2025
Q2
$17.9M Buy
130,537
+65,275
+100% +$9.59M 0.02% 534
2025
Q1
$11.8M Sell
65,262
-46,827
-42% -$7.88M 0.01% 617
2024
Q4
$17.6M Sell
112,089
-3,261
-3% -$578K 0.02% 542
2024
Q3
$21M Sell
115,350
-22,083
-16% -$4.26M 0.02% 487
2024
Q2
$25.2M Sell
137,433
-5,527
-4% -$928K 0.03% 408
2024
Q1
$25.4M Sell
142,960
-49,915
-26% -$6.93M 0.03% 436
2023
Q4
$23.9M Sell
192,875
-180,937
-48% -$20.1M 0.03% 437
2023
Q3
$43.4M Buy
+373,812
New +$45.6M 0.05% 309

Other funds holding KRYS